Effect of vasoactive therapy on heart rate variability in patients with acutely decompensated congestive heart failure

American Journal of Cardiology

Volumn 84, Issue 4, 1999, Pages 476-478

  Burger, Andrew J ^a   Aronson, Doron ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; GLYCERYL TRINITRATE; MILRINONE; NITROPRUSSIDE SODIUM; VASOACTIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART RATE VARIABILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; AUTONOMIC NERVOUS SYSTEM; CARDIOTONIC AGENTS; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0033566832     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00340-9     Document Type: Article

References (20)

1. Packer M. The neurohormonal hypothesis a theory to explain the mechanism of disease progression in heart failure . J Am Coll Cardiol. 20:1992;248-254.
2. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., Simon A.B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 311:1984;819-823.
3. Binkley P.F., Haas G.J., Starling R.C., Nunziata E., Hatton P.A., Leier C.V., Cody R.J. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol. 21:1993;655-661.
4. Nolan J., Batin P.D., Andrews R., Lindsay S.J., Brooksby P., Mullen M., Baig W., Flapan A.D., Cowley A., Prescott R.J., Neilson J.M., Fox K.A. Prospective study of heart rate variability and mortality in chronic heart failure results of the united kingdom heart failure evaluation and assessment of risk trial (UK-heart) . Circulation. 98:1998;1510-1516.
5. Fauchier L., Babuty D., Cosnay P., Autret M.L., Fauchier J.P. Heart rate variability in idiopathic dilated cardiomyopathy characteristics and prognostic value . J Am Coll Cardiol. 30:1997;1009-1014.
6. Jiang W., Hathaway W.R., McNulty S., Larsen R.L., Hansley K.L., Zhang Y., O'Connor C.M. Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol. 80:1997;808-811.
7. Pousset F., Copie X., Lechat P., Jaillon P., Boissel J.P., Hetzel M., Fillette F., Remme W., Guize L., Le Heuzey J.Y. Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol. 77:1996;612-617.
8. Bourge R., Abraham W., Wagoner L., Horton D. Nesiritide improves hemodynamics in patients with acutely decompensated heart failure hemodynamic subgroup analysis . Circulation. 98:(suppl I):1998;I-578.
9. Heart rate variability standards of measurement, physiological interpretation and clinical use . Circulation. 93:1996;1043-1065.
10. Luria M.H., Sapoznikov D., Gilon D., Zahger D., Weinstein J.M., Weiss A.T., Gotsman M.S. Early heart rate variability alterations after acute myocardial infarction. Am Heart J. 125:1993;676-681.
11. Singh N., Mironov D., Armstrong P.W., Ross A.M., Langer A. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries. Circulation. 93:1996;1388-1395.
12. Barber M.J., Mueller T.M., Davies B.G., Gill R.M., Zipes D.P. Interruption of sympathetic and vagal-mediated afferent responses by transmural myocardial infarction. Circulation. 72:1985;623-631.
13. Schwartz P.J., Vanoli E., Stramba-Badiale M., De Ferrari G.M., Billman G.E., Foreman R.D. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation. 78:1988;969-979.
14. Minisi A.J., Thames M.D. Effect of chronic myocardial infarction on vagal cardiopulmonary baroreflex. Circ Res. 65:1989;396-405.
15. Butler G.C., Naughton M.T., Rahman M.A., Bradley T.D., Floras J.S. Continuous positive airway pressure increases heart rate variability in congestive heart failure. J Am Coll Cardiol. 25:1995;672-679.
16. Kim S.Y., Montoya A., Zbilut J.P., Mawulawde K., Sullivan H.J., Lonchyna V.A., Terrell M.R., Pifarre R. Effect of HeartMate left ventricular assist device on cardiac autonomic nervous activity. Ann Thorac Surg. 61:1996;591-593.
17. Mortara A., Sleight P., Pinna G.D., Maestri R., Prpa A., La Rovere M.T., Cobelli F., Tavazzi L. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation. 96:1997;246-252.
18. Mortara A., La Rovere M.T., Pinna G.D., Prpa A., Maestri R., Febo O., Pozzoli M., Opasich C., Tavazzi L. Arterial baroreflex modulation of heart rate in chronic heart failure clinical and hemodynamic correlates and prognostic implications . Circulation. 96:1997;3450-3458.
19. Ponikowski P., Chua T.P., Piepoli M., Ondusova D., Webb-Peploe K., Harrington D., Anker S.D., Volterrani M., Colombo R., Mazzuero G., Giordano A., Coats A.J. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation. 96:1997;2586-2594.
20. Szabo B.M., van Veldhuisen D.J., Brouwer J., Haaksma J., Lie K.I. Relation between severity of disease and impairment of heart rate variability parameters in patients with chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol. 76:1995;713-716.